R87.61AktuellKategorie · weitere Spezifizierung erforderlich

Abnormal cytological findings in specimens from cervix uteri

Hinweise zum Code

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

R83-R89 · Hinweise übergeordneter Ebenen

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2 · 9

R87.61

Excludes 2

cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

Spezifischere Codes

R87.610Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)R87.611Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)R87.612Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)R87.613High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)R87.614Cytologic evidence of malignancy on smear of cervix R87.615Unsatisfactory cytologic smear of cervix R87.616Satisfactory cervical smear but lacking transformation zone R87.618Other abnormal cytological findings on specimens from cervix uteri R87.619Unspecified abnormal cytological findings in specimens from cervix uteri

Abrechnung und Kostenübernahme

Wann ICD-10-CM vorgeschrieben ist

Für US-Diagnoseabrechnungen nach HIPAA ist ICD-10-CM seit dem 1. Oktober 2015 vorgeschrieben.

Für ambulante und ärztliche Abrechnungen gilt das Leistungsdatum, für stationäre Krankenhausfälle das Entlassungsdatum. Frühere Behandlungen verwenden ICD-9-CM; auch der einzelne Code muss am maßgeblichen Datum gültig sein.

Offizielle Kodierrichtlinien → · CMS ↗

Erstmals erfasst · 2015-10-01

Codeverlauf

Keine Änderung seit der ersten Erfassung

GeändertUnverändert

FY2016

Gültig ab 2015-10-01

Erstmals erfasst

Abnormal cytological findings in specimens from cervix uteri

Kategorie — spezifischeren Code auswählen

CDC/NCHS · FY2016

Alle Ausgaben (19)

Alle Ausgaben	Gültig ab	Codeverlauf
FY2016	2015-10-01	Erstmals erfasst
FY2017	2016-10-01	Keine tabellarische Änderung
FY2018	2017-10-01	Keine tabellarische Änderung
FY2019	2018-10-01	Keine tabellarische Änderung
FY2020	2019-10-01	Keine tabellarische Änderung
FY2020 · April	2020-04-01	Keine tabellarische Änderung
FY2021	2020-10-01	Keine tabellarische Änderung
FY2021 · 01-01	2021-01-01	Keine tabellarische Änderung
FY2022	2021-10-01	Keine tabellarische Änderung
FY2022 · 04-01	2022-04-01	Keine tabellarische Änderung
FY2023	2022-10-01	Keine tabellarische Änderung
FY2023 · 04-01	2023-04-01	Keine tabellarische Änderung
FY2024	2023-10-01	Keine tabellarische Änderung
FY2024 · 04-01	2024-04-01	Keine tabellarische Änderung
FY2025	2024-10-01	Keine tabellarische Änderung
FY2025 · 04-01	2025-04-01	Keine tabellarische Änderung
FY2026	2025-10-01	Keine tabellarische Änderung
FY2026 · April	2026-04-01	Keine tabellarische Änderung
FY2027	2026-10-01	Keine tabellarische Änderung

Hinweise zum Code

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

Excludes 2

cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Hinweise übergeordneter Ebenen

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

Note

This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
The conditions and signs or symptoms included in categories R00-R94 consist of:
(a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
(b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
(c) provisional diagnosis in a patient who failed to return for further investigation or care;
(d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
(e) cases in which a more precise diagnosis was not available for any other reason;
(f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

R87 · Abnormal findings in specimens from female genital organs

Includes

abnormal findings in secretion and smears from cervix uteri
abnormal findings in secretion and smears from vagina
abnormal findings in secretion and smears from vulva

Spezifischere Codes

Abnormal cytological findings in specimens from cervix uteri

Hinweise zum Code

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

R83-R89 · Hinweise übergeordneter Ebenen

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2 · 9

R87.61

Excludes 2

cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

Spezifischere Codes

Abrechnung und Kostenübernahme

Wann ICD-10-CM vorgeschrieben ist

Für US-Diagnoseabrechnungen nach HIPAA ist ICD-10-CM seit dem 1. Oktober 2015 vorgeschrieben.

Offizielle Kodierrichtlinien → · CMS ↗

Erstmals erfasst · 2015-10-01

Codeverlauf

Keine Änderung seit der ersten Erfassung

GeändertUnverändert

FY2016

Gültig ab 2015-10-01

Erstmals erfasst

Abnormal cytological findings in specimens from cervix uteri

Kategorie — spezifischeren Code auswählen

CDC/NCHS · FY2016

Alle Ausgaben (19)

Alle Ausgaben	Gültig ab	Codeverlauf
FY2016	2015-10-01	Erstmals erfasst
FY2017	2016-10-01	Keine tabellarische Änderung
FY2018	2017-10-01	Keine tabellarische Änderung
FY2019	2018-10-01	Keine tabellarische Änderung
FY2020	2019-10-01	Keine tabellarische Änderung
FY2020 · April	2020-04-01	Keine tabellarische Änderung
FY2021	2020-10-01	Keine tabellarische Änderung
FY2021 · 01-01	2021-01-01	Keine tabellarische Änderung
FY2022	2021-10-01	Keine tabellarische Änderung
FY2022 · 04-01	2022-04-01	Keine tabellarische Änderung
FY2023	2022-10-01	Keine tabellarische Änderung
FY2023 · 04-01	2023-04-01	Keine tabellarische Änderung
FY2024	2023-10-01	Keine tabellarische Änderung
FY2024 · 04-01	2024-04-01	Keine tabellarische Änderung
FY2025	2024-10-01	Keine tabellarische Änderung
FY2025 · 04-01	2025-04-01	Keine tabellarische Änderung
FY2026	2025-10-01	Keine tabellarische Änderung
FY2026 · April	2026-04-01	Keine tabellarische Änderung
FY2027	2026-10-01	Keine tabellarische Änderung

Hinweise zum Code

Excludes 1

abnormal cytological findings in specimens from other female genital organs (R87.69)
abnormal cytological findings in specimens from vagina (R87.62-)
carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
cervical intraepithelial neoplasia I [CIN I] (N87.0)
cervical intraepithelial neoplasia II [CIN II] (N87.1)
cervical intraepithelial neoplasia III [CIN III] (D06.-)
dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

Excludes 2

cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

Hinweise übergeordneter Ebenen

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

Excludes 2

abnormal findings on antenatal screening of mother (O28.-)
certain conditions originating in the perinatal period (P04-P96)
signs and symptoms classified in the body system chapters
signs and symptoms of breast (N63, N64.5)

Note

This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
The conditions and signs or symptoms included in categories R00-R94 consist of:
(a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
(b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
(c) provisional diagnosis in a patient who failed to return for further investigation or care;
(d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
(e) cases in which a more precise diagnosis was not available for any other reason;
(f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Excludes 1

abnormal findings on antenatal screening of mother (O28.-)
diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes 2

abnormal findings on examination of blood, without diagnosis (R70-R79)
abnormal findings on examination of urine, without diagnosis (R80-R82)
abnormal tumor markers (R97.-)

R87 · Abnormal findings in specimens from female genital organs

Includes

abnormal findings in secretion and smears from cervix uteri
abnormal findings in secretion and smears from vagina
abnormal findings in secretion and smears from vulva

Abnormal cytological findings in specimens from cervix uteri

Hinweise zum Code

R83-R89 · Hinweise übergeordneter Ebenen

R87.61

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Spezifischere Codes

Abrechnung und Kostenübernahme

Codeverlauf

Alle Ausgaben (19)

Hinweise zum Code

Hinweise übergeordneter Ebenen

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

R87 · Abnormal findings in specimens from female genital organs

Spezifischere Codes

Verwandte Codes

Abnormal cytological findings in specimens from cervix uteri

Hinweise zum Code

R83-R89 · Hinweise übergeordneter Ebenen

R87.61

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

Spezifischere Codes

Abrechnung und Kostenübernahme

Codeverlauf

Alle Ausgaben (19)

Hinweise zum Code

Hinweise übergeordneter Ebenen

Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)

R83-R89 · Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis (R83-R89)

R87 · Abnormal findings in specimens from female genital organs

Spezifischere Codes

Verwandte Codes

Code	Beschreibung	Kategorie · weitere Spezifizierung erforderlich
R87.62	Abnormal cytological findings in specimens from vagina	Kategorie · weitere Spezifizierung erforderlich
R87.69	Abnormal cytological findings in specimens from other female genital organs	Abrechenbarer, spezifischer Code